New England’s tech and life sciences companies were busy this week. Here are some of the deals they inked.
—Waltham, MA-based research tools and services provider Thermo Fisher Scientific (NYSE:TMO) announced plans to buy Lomb Scientific—an Australian maker of lab chemicals, consumables, and instruments—for an undisclosed sum.
—LineSider Technologies, a Danvers, MA-based maker of network management software, agreed to be acquired by San Jose, CA-based Cisco Systems (NASDAQ: CSCO), also for an undisclosed sum.
—Cambridge, MA-based Aveo Pharmaceuticals (NASDAQ:AVEO) scored a $12.5 million payment when OSI Pharmaceuticals exercised an option to internalize Aveo’s technology for making animal models of human cancers. Aveo will get a second payment of the same amount when it transfers the technology to OSI in July 2011.
—Whitehouse Station, NJ-based pharma behemoth Merck agreed to buy out Beverly, MA-based diabetes treatment developer SmartCells in a deal that could be worth more than $500 million, if certain development and regulatory milestones are met. Ryan talked with SmartCells co-founder and CEO Todd Zion about the angel-backed startup’s unconventional path to a big exit.
—Mobile software maker Azuki Systems sold $4 million of a planned $8 equity and rights offering. Kepha Partners and Sigma Partners are among the Acton, MA-based startup’s backers.
—Boston-based energy management company EnerNOC (NASDAQ: ENOC) acquired Walnut Creek, CA-based Global Energy Partners, a provider of energy and environmental engineering services, in the largest of a string of acquisitions that EnerNoc’s made over the last few years.
—NaviNet, the Cambridge, MA-based operator of a real-time healthcare communications network, acquired McLean, VA-base Prematics, a provider of mobile clinical messaging and e-prescribing tools, for an undisclosed sum.
—Boston’s Fluent Mobile, maker of the news-aggregating iPhone app Fluent News, closed a $5.5 million funding round, according to a regulatory filing.
—Lead-generation software maker NetProspex of Waltham raised $5.5 million in a Series B financing led by Edison Venture Fund and joined by angel investors who participated in the firm’s $2 million Series A round.